Double Medical Technology Inc
SZSE:002901

Watchlist Manager
Double Medical Technology Inc Logo
Double Medical Technology Inc
SZSE:002901
Watchlist
Price: 32.41 CNY -1.01% Market Closed
Market Cap: 13.4B CNY
Have any thoughts about
Double Medical Technology Inc?
Write Note

Double Medical Technology Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Double Medical Technology Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Double Medical Technology Inc
SZSE:002901
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Depreciation & Amortization
-ÂĄ41.2m
CAGR 3-Years
-61%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Depreciation & Amortization
-ÂĄ138.5m
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Double Medical Technology Inc
Glance View

Market Cap
13.4B CNY
Industry
Health Care

Double Medical Technology, Inc. engages in production, research and development and sale of medical consumables. The company is headquartered in Xiamen, Fujian and currently employs 3,141 full-time employees. The company went IPO on 2017-09-22. The main products of the Company include orthopedic trauma implant materials, spinal implant materials and nerve surgical implant materials. Also, the Company manufactures surgical instruments. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
31.28 CNY
Overvaluation 3%
Intrinsic Value
Price

See Also

Back to Top